1. Home
  2. OBAI vs ENLV Comparison

OBAI vs ENLV Comparison

Compare OBAI & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG-17 Inc. Common Stock

OBAI

TG-17 Inc. Common Stock

HOLD

Current Price

$0.23

Market Cap

9.4M

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.48

Market Cap

10.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBAI
ENLV
Founded
2017
2005
Country
United States
Israel
Employees
N/A
34
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4M
10.4M
IPO Year
2025
2014

Fundamental Metrics

Financial Performance
Metric
OBAI
ENLV
Price
$0.23
$0.48
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $20.00
AVG Volume (30 Days)
★ 558.8K
377.9K
Earning Date
05-27-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 40.53
N/A
EPS
N/A
★ N/A
Revenue
★ $9,972,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 2.42
N/A
52 Week Low
$0.21
$0.43
52 Week High
$19.95
$7.64

Technical Indicators

Market Signals
Indicator
OBAI
ENLV
Relative Strength Index (RSI) 33.79 21.85
Support Level N/A $0.43
Resistance Level $0.65 $1.26
Average True Range (ATR) 0.03 0.11
MACD -0.00 0.01
Stochastic Oscillator 25.25 1.42

Price Performance

Historical Comparison
OBAI
ENLV

About OBAI TG-17 Inc. Common Stock

Our Bond Inc is a personal security service through its AI-powered Preventive Personal Security platform. It is trusted by corporations, cities, and universities, and has already supported many security service requests, emergencies and life-saving interventions. The cloud-based Bond Preventative Personal Security Platform provides users with remote protective services via phone app (using its Bond Preventative Personal Security Platform) and with 24/7 support from its Personal Security Agents, who are in Bond Command Centers and can respond rapidly. It offers distinct services through its phone app (the Bond App) and fully automated Bond Command Centers. Geographically, the company operates in Israel, France, and United States. It derives maximum revenue from United States.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: